Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Outcomes From HD-tDCS Intervention in Long COVID-19 Using Electroencephalographic Biomarkers and Machine Learning Approach.

NCT05289128 is registered in ClinicalTrials.gov with Federal University of Paraíba as lead sponsor.

NCT NCT05289128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Outcomes From HD-tDCS Intervention in Long COVID-19 Using Electroencephalographic Biomarkers and Machine Learning Approach.
Lead sponsor
Federal University of Paraíba
Phase
Not applicable
Overall status
Unknown status
Start date
February 7, 2022
Completion date
July 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus covid-19, respiratory infection